Last reviewed · How we verify

Pantoprazole 40mg, Amoxicillin and Levofloxacin

Ain Shams University · Phase 3 active Small molecule

Pantoprazole 40mg, Amoxicillin and Levofloxacin is a Proton pump inhibitor + antibiotic combination Small molecule drug developed by Ain Shams University. It is currently in Phase 3 development for Helicobacter pylori eradication in peptic ulcer disease, Gastritis associated with H. pylori infection. Also known as: controloc 40 mg, Amoxil 1 gm, Tavanic 500 mg.

This is a triple-therapy combination that suppresses gastric acid while simultaneously targeting bacterial pathogens associated with peptic ulcer disease and gastritis.

This is a triple-therapy combination that suppresses gastric acid while simultaneously targeting bacterial pathogens associated with peptic ulcer disease and gastritis. Used for Helicobacter pylori eradication in peptic ulcer disease, Gastritis associated with H. pylori infection.

At a glance

Generic namePantoprazole 40mg, Amoxicillin and Levofloxacin
Also known ascontroloc 40 mg, Amoxil 1 gm, Tavanic 500 mg
SponsorAin Shams University
Drug classProton pump inhibitor + antibiotic combination
TargetH+/K+-ATPase (pantoprazole); bacterial DNA gyrase and topoisomerase IV (levofloxacin); bacterial cell wall (amoxicillin)
ModalitySmall molecule
Therapeutic areaGastroenterology
PhasePhase 3

Mechanism of action

Pantoprazole is a proton pump inhibitor that blocks gastric acid secretion by inhibiting the H+/K+-ATPase pump in parietal cells. Amoxicillin and levofloxacin are broad-spectrum antibiotics that work synergistically to eradicate Helicobacter pylori and other pathogenic bacteria. Together, this combination addresses both the acid-related damage and the underlying bacterial infection.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Pantoprazole 40mg, Amoxicillin and Levofloxacin

What is Pantoprazole 40mg, Amoxicillin and Levofloxacin?

Pantoprazole 40mg, Amoxicillin and Levofloxacin is a Proton pump inhibitor + antibiotic combination drug developed by Ain Shams University, indicated for Helicobacter pylori eradication in peptic ulcer disease, Gastritis associated with H. pylori infection.

How does Pantoprazole 40mg, Amoxicillin and Levofloxacin work?

This is a triple-therapy combination that suppresses gastric acid while simultaneously targeting bacterial pathogens associated with peptic ulcer disease and gastritis.

What is Pantoprazole 40mg, Amoxicillin and Levofloxacin used for?

Pantoprazole 40mg, Amoxicillin and Levofloxacin is indicated for Helicobacter pylori eradication in peptic ulcer disease, Gastritis associated with H. pylori infection.

Who makes Pantoprazole 40mg, Amoxicillin and Levofloxacin?

Pantoprazole 40mg, Amoxicillin and Levofloxacin is developed by Ain Shams University (see full Ain Shams University pipeline at /company/ain-shams-university).

Is Pantoprazole 40mg, Amoxicillin and Levofloxacin also known as anything else?

Pantoprazole 40mg, Amoxicillin and Levofloxacin is also known as controloc 40 mg, Amoxil 1 gm, Tavanic 500 mg.

What drug class is Pantoprazole 40mg, Amoxicillin and Levofloxacin in?

Pantoprazole 40mg, Amoxicillin and Levofloxacin belongs to the Proton pump inhibitor + antibiotic combination class. See all Proton pump inhibitor + antibiotic combination drugs at /class/proton-pump-inhibitor-antibiotic-combination.

What development phase is Pantoprazole 40mg, Amoxicillin and Levofloxacin in?

Pantoprazole 40mg, Amoxicillin and Levofloxacin is in Phase 3.

What are the side effects of Pantoprazole 40mg, Amoxicillin and Levofloxacin?

Common side effects of Pantoprazole 40mg, Amoxicillin and Levofloxacin include Diarrhea, Nausea, Headache, Abdominal pain, Rash, Tendinopathy (levofloxacin-related).

What does Pantoprazole 40mg, Amoxicillin and Levofloxacin target?

Pantoprazole 40mg, Amoxicillin and Levofloxacin targets H+/K+-ATPase (pantoprazole); bacterial DNA gyrase and topoisomerase IV (levofloxacin); bacterial cell wall (amoxicillin) and is a Proton pump inhibitor + antibiotic combination.

Related